About the Group : The Analytical Development group within the newly formed Targeted LNP (tLNP) CMC Team at AbbVie that is dedicated to advancing state-of-the-art analytical capabilities for mRNA-lipid nanoparticle therapeutics. Our team provides critical support across drug substance (DS) and drug product (DP) manufacturing, drug product formulation, and the development and implementation of robust analytical methodologies to ensure the quality, safety and integrity of tLNP genetic medicines. We leverage advanced biophysical, separations, and mass spectrometry techniques to deeply characterize intact LNP particles. We foster close collaborations with cross-functional colleagues in CMC, drug product formulation, and external partners, and are currently growing a world-class team of scientists who will be instrumental in building and deploying the analytical toolbox necessary to deliver high-quality, innovative tLNP medicines to patients. Position Overview: As a Lipids SME within the Analytical Development team of AbbVie’s Targeted LNP (tLNP) CMC organization, you will be responsible for leading the analytical activities relevant to lipids components. Develops, establishes and validates testing methods used to control individual lipid starting material and final assembled lipids component in the DP. Responsible for development and implementation of control strategies for individual lipid starting material and final assembled lipids component in the DP. Responsible for keeping work in compliance with cGMP, safety and regulatory requirements. Additionally, the candidate must foster productive collaborations within the global Analytical CMC organization and with R&D cross-functional partners such as Discovery, Pre-Clinical Safety, Process Chemistry, Process Engineering, Drug Product Development, and Quality Assurance and CMC-Regulatory Affairs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level